Literature DB >> 12669959

Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers.

Staffan Tavelin1, Jan Taipalensuu, Lauri Söderberg, Rick Morrison, Saeho Chong, Per Artursson.   

Abstract

PURPOSE: To characterize the paracellular route of 2/4/A1 monolayers and to compare the permeabilities of incompletely absorbed oral drugs in 2/4/A1 with those in Caco-2 monolayers.
METHODS: The cells were cultivated on permeable supports. The 2/4/ A1 expression of genes associated with tight junctions was compared with that in the small intestine using RT-PCR. The aqueous pore radii were determined using paracellular marker molecules. The permeabilities of a series of incompletely absorbed drugs (defined as having a fraction absorbed 0 to 80%) after oral administration to humans were studied.
RESULTS: Occludin and claudin 1 and 3 were expressed in 2/4/A1. The pore radius of 2/4/A1 was 9.0 +/- 0.2 A. which is similar to that in the human small intestine, although the pore radius was smaller (3.7 +/- 0.1 A) in Caco-2. The relationship between permeability and fraction absorbed of 13 drugs was stronger in 2/4/A1 than in Caco-2. The relationships were used to predict the intestinal absorption of another seven drugs. The prediction was more accurate in 2/4/A1 (RMSE = 15.6%) than in Caco-2 (RMSE = 21.1%). Further, Spearman's rank coefficient between FA and permeability was higher in 2/4/A1.
CONCLUSION: The improved 2/4/A1 cell culture model has a more in vivo-like permeability and predicted the oral absorption of incompletely absorbed drugs better than Caco-2 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669959     DOI: 10.1023/a:1022699920043

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  42 in total

1.  Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors.

Authors:  Y H Zhao; J Le; M H Abraham; A Hersey; P J Eddershaw; C N Luscombe; D Butina; G Beck; B Sherborne; I Cooper; J A Platts; D Boutina
Journal:  J Pharm Sci       Date:  2001-06       Impact factor: 3.534

2.  Effect of changing intestinal flow rate on a measurement of intestinal permeability.

Authors:  K D Fine; C A Santa Ana; J L Porter; J S Fordtran
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

3.  Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.

Authors:  A Collett; E Sims; D Walker; Y L He; J Ayrton; M Rowland; G Warhurst
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

4.  Saturable transport of H2-antagonists ranitidine and famotidine across Caco-2 cell monolayers.

Authors:  K Lee; D R Thakker
Journal:  J Pharm Sci       Date:  1999-07       Impact factor: 3.534

5.  Contributions of saturable active secretion, passive transcellular, and paracellular diffusion to the overall transport of furosemide across adenocarcinoma (Caco-2) cells.

Authors:  Shawn D Flanagan; Lpori H Takahashi; Xiaoli Liu; Leslie Z Benet
Journal:  J Pharm Sci       Date:  2002-04       Impact factor: 3.534

6.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.

Authors:  S Winiwarter; N M Bonham; F Ax; A Hallberg; H Lennernäs; A Karlén
Journal:  J Med Chem       Date:  1998-12-03       Impact factor: 7.446

7.  Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.

Authors:  M C Grès; B Julian; M Bourrié; V Meunier; C Roques; M Berger; X Boulenc; Y Berger; G Fabre
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

8.  Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue.

Authors:  W Rubas; M E Cromwell; Z Shahrokh; J Villagran; T N Nguyen; M Wellton; T H Nguyen; R J Mrsny
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

9.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

Authors:  P Artursson
Journal:  J Pharm Sci       Date:  1990-06       Impact factor: 3.534

10.  Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells.

Authors:  M Furuse; K Furuse; H Sasaki; S Tsukita
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

View more
  20 in total

1.  An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routes.

Authors:  Staffan Tavelin; Jan Taipalensuu; Finn Hallböök; Kati-Sisko Vellonen; Vanessa Moore; Per Artursson
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

Review 2.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

3.  The prediction of human oral absorption for diffusion rate-limited drugs based on heuristic method and support vector machine.

Authors:  H X Liu; R J Hu; R S Zhang; X J Yao; M C Liu; Z D Hu; B T Fan
Journal:  J Comput Aided Mol Des       Date:  2005-01       Impact factor: 3.686

Review 4.  A cheminformatic toolkit for mining biomedical knowledge.

Authors:  Gus R Rosania; Gordon Crippen; Peter Woolf; David States; Kerby Shedden
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

Review 5.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

6.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

7.  Orally active antiviral tripeptide glycyl-prolyl-glycinamide is activated by CD26 (dipeptidyl peptidase IV) before transport across the intestinal epithelium.

Authors:  Ina Hubatsch; Lucia Lazorova; Anders Vahlne; Per Artursson
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

8.  Claudin-2-dependent changes in noncharged solute flux are mediated by the extracellular domains and require attachment to the PDZ-scaffold.

Authors:  Christina M Van Itallie; Jennifer Holmes; Arlene Bridges; James Melvin Anderson
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

9.  Voltage dependence of transepithelial guanidine permeation across Caco-2 epithelia allows determination of the paracellular flux component.

Authors:  Georgina Carr; Iain S Haslam; Nicholas L Simmons
Journal:  Pharm Res       Date:  2006-03-10       Impact factor: 4.200

10.  Leakiness and size exclusion of paracellular channels in cultured epithelial cell monolayers-interlaboratory comparison.

Authors:  Alex Avdeef
Journal:  Pharm Res       Date:  2010-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.